Dynamic cortical inhibition imbalance as a biomarker of clinical progression in early Parkinson's disease. Li P, Zhou X, Luo N, Zhou S, et al. Neurobiol Dis 2025 Sep 3:107083. doi: 10.1016/j.nbd.2025.107083.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li P, Zhou X, Luo N, Zhou S, et al. Dynamic cortical inhibition imbalance as a biomarker of clinical progression in early Parkinson's disease. Neurobiol Dis 2025 Sep 3:107083. doi: 10.1016/j.nbd.2025.107083.
PMID: 40912410